Spago Nanomedical AB (SPAGO) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.201x

Based on the latest financial reports, Spago Nanomedical AB (SPAGO) has a cash flow conversion efficiency ratio of -0.201x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.19 Million ≈ $-665.71K USD) by net assets (Skr30.75 Million ≈ $3.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Spago Nanomedical AB stock valuation for the company's overall valuation and market capitalisation.

Spago Nanomedical AB - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Spago Nanomedical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Spago Nanomedical AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spago Nanomedical AB ranked by their cash flow conversion efficiency. See Spago Nanomedical AB debt service capacity to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
JPMorgan Global Emerging Markets Investment Trust PLC LSE:JEMI	0.010x
Future Market Networks Limited NSE:FMNL	0.072x
TechnoDex Bhd KLSE:0132	-0.011x
Robogroup TA:ROBO	-0.260x
X2M Connect Ltd AU:X2M	-0.024x
AGROB Immobilien AG F:AGR3	N/A
CEA Industries Inc NASDAQ:CEAD	-0.091x
ALTECH ADV.MAT. NA O.N. F:AMA	N/A

Annual Cash Flow Conversion Efficiency for Spago Nanomedical AB (2011–2025)

The table below shows the annual cash flow conversion efficiency of Spago Nanomedical AB from 2011 to 2025. View Spago Nanomedical AB (SPAGO) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr30.75 Million ≈ $3.31 Million	Skr-28.30 Million ≈ $-3.05 Million	-0.920x	+11.77%
2024-12-31	Skr33.23 Million ≈ $3.58 Million	Skr-34.67 Million ≈ $-3.73 Million	-1.043x	+4.03%
2023-12-31	Skr41.32 Million ≈ $4.45 Million	Skr-44.91 Million ≈ $-4.83 Million	-1.087x	-461.18%
2022-12-31	Skr197.16 Million ≈ $21.22 Million	Skr-38.19 Million ≈ $-4.11 Million	-0.194x	-0.64%
2021-12-31	Skr184.81 Million ≈ $19.89 Million	Skr-35.57 Million ≈ $-3.83 Million	-0.192x	-63.76%
2020-12-31	Skr159.67 Million ≈ $17.18 Million	Skr-18.77 Million ≈ $-2.02 Million	-0.118x	+24.02%
2019-12-31	Skr137.63 Million ≈ $14.81 Million	Skr-21.29 Million ≈ $-2.29 Million	-0.155x	-79.87%
2018-12-31	Skr122.22 Million ≈ $13.15 Million	Skr-10.51 Million ≈ $-1.13 Million	-0.086x	-19.90%
2017-12-31	Skr107.78 Million ≈ $11.60 Million	Skr-7.73 Million ≈ $-831.87K	-0.072x	+34.47%
2016-12-31	Skr71.84 Million ≈ $7.73 Million	Skr-7.86 Million ≈ $-846.18K	-0.109x	-33.92%
2015-12-31	Skr65.41 Million ≈ $7.04 Million	Skr-5.34 Million ≈ $-575.21K	-0.082x	+23.04%
2014-12-31	Skr56.05 Million ≈ $6.03 Million	Skr-5.95 Million ≈ $-640.53K	-0.106x	+47.60%
2013-12-31	Skr38.18 Million ≈ $4.11 Million	Skr-7.74 Million ≈ $-832.62K	-0.203x	-1324.77%
2012-12-31	Skr42.25 Million ≈ $4.55 Million	Skr-601.00K ≈ $-64.68K	-0.014x	+33.80%
2011-12-31	Skr12.84 Million ≈ $1.38 Million	Skr-276.00K ≈ $-29.70K	-0.021x	--

About Spago Nanomedical AB

ST:SPAGO Sweden Biotechnology

Market Cap

$6.66 Million

Skr61.92 Million SEK

Market Cap Rank

#28087 Global

#617 in Sweden

Share Price

Skr0.09

Change (1 day)

-5.45%

52-Week Range

Skr0.09 - Skr0.33

All Time High

Skr19.04